نتائج البحث

1

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

المؤلفون: Jianying Zhou, Caicun Zhou, Zhehai Wang, Chengping Hu, Wen Zhang, Dingzhi Huang, Lianke Liu, H. Zhao, Shundong Cang, Jianxin Xue, Chengzhi Zhou, Jian Fang, Li Zhang, Gongyan Chen, Zhixiong Yang, Ping Sun, Min Fan, Hui Zhou, Juan Li, Jiuwei Cui, Lin Wu, Baolan Li, Yingying Du, Yun Fan, Yuping Li, Shuyan Wang

المصدر: Journal of Thoracic Oncology. 16:1501-1511

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ae08ff7166f291e1979183f19d3e976cTest
https://doi.org/10.1016/j.jtho.2021.04.011Test

2

Occurrence of hypertension during third‐line anlotinib is associated with progression‐free survival in patients with squamous cell lung cancer (SCC): A post hoc analysis of the ALTER0303 trial

المؤلفون: Jian Dong, Weiqiang Chen, Xiuxiu Wang, Zhehai Wang, Yi Luo, Ying Cheng, Yuankai Shi, Baohui Han, Jianhua Shi, Haitao Wang, Xiuwen Wang, Li Zhang, Guimin Chen, Kai Li, Jianxing He, Qiming Wang, Baolan Li, Faguang Jin, Lin Wu, Kejun Nan, Zhian Liu

المصدر: Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 17, Pp 2345-2351 (2021)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, squamous cell carcinoma, Adult, Male, medicine.medical_specialty, hypertension, Indoles, Lung Neoplasms, Squamous cell lung cancer, survival, law.invention, Randomized controlled trial, Double-Blind Method, law, Internal medicine, Post-hoc analysis, medicine, anlotinib, Humans, In patient, Progression-free survival, Lung cancer, neoplasms, RC254-282, Aged, ECOG Score, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, General Medicine, Original Articles, Middle Aged, medicine.disease, Progression-Free Survival, lung cancer, Third line, Carcinoma, Squamous Cell, Quinolines, Original Article, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d88989a61a8cd59f61e5dcd254185c2Test
http://europepmc.org/articles/PMC8410552Test

3

Driver gene alterations in lung adenocarcinoma: Demographic features of 2544 Chinese cases

المؤلفون: Nanying Che, Yuan Yang, Baolan Li, Zichen Liu, Mingming Hu, Jie Li, Tongmei Zhang

المصدر: The International Journal of Biological Markers. 35:44-50

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8b76ad220cec5013c763851859aac27Test
https://doi.org/10.1177/1724600820967015Test

4

Effect of anlotinib as a third‐ or further‐line therapy in advanced non‐small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial

المؤلفون: Weiqiang Chen, Xiuwen Wang, Kejun Nan, Li Zhang, Jianxing He, Baohui Han, Jing Zhu, Zhehai Wang, Kai Li, Baolan Li, Faguang Jin, Qiming Wang, Yi Luo, Ying Cheng, Jianhua Shi, Yuankai Shi

المصدر: Cancer Medicine, Vol 9, Iss 8, Pp 2621-2630 (2020)
Cancer Medicine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85c71178d0f1b1011129c0a59a412f98Test
https://doaj.org/article/d4fedd9759804f7bb2adee9ef4881b82Test

5

Biosimilar candidate IBI305 plus paclitaxel/carboplatin for the treatment of non-squamous non-small cell lung cancer

المصدر: Translational Lung Cancer Research. 8:989-999

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6c7c193fbe786e18aaa2fdaa1745a08Test
https://doi.org/10.21037/tlcr.2019.12.23Test

6

Updated Overall Survival Data and Predictive Biomarkers of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC in the Phase 3 ORIENT-11 Study

المؤلفون: Christoph Mancao, Yong Song, Weimin Li, Jifeng Feng, Jian Fang, Wenfeng Fang, Bo Peng, Zhixiong Yang, Shundong Cang, Qitao Yu, Zhehai Wang, Hui Zhou, Jianying Zhou, Gongyan Chen, Juan Li, Xiaodong Mei, Luyao Sun, Jiya Sun, Oscar Puig, Li Zhang, Shuyan Wang, Rui Zhou, Rui Ma, Xiubao Ren, M. Bi, You Lu, Baohui Han, Yunpeng Yang, Zhiyong He, Wei Xu, Baolan Li

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 16(12)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de7ce8bbbf8321308b8a04bc581ada8cTest
https://pubmed.ncbi.nlm.nih.gov/34358724Test

7

VP9-2021: ORIENT-31: Phase III study of sintilimab with or without IBI305 plus chemotherapy in patients with EGFR mutated nonsquamous NSCLC who progressed after EGFR-TKI therapy

المؤلفون: Ke Wang, Yueyin Pan, A. Liu, Li Xuyan, Shun Lu, L. Han, L. Miao, Jiuwei Cui, Qian Wang, Baolan Li, Yali Hu, Zhenghang Wang, Lingqian Wu, M. Sun, S. Cang, Yung-Chi Cheng, Hong Jian, Cuimin Ding, Jingyun Fang, Feng Ye

المصدر: Annals of Oncology. 33:112-113

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Chemotherapy, Egfr tki, business.industry, medicine.medical_treatment, Internal medicine, medicine, In patient, Hematology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::60d3551b03e7599171f48ea844501b37Test
https://doi.org/10.1016/j.annonc.2021.10.007Test

8

Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer

المؤلفون: Zhehai Wang, Yi Luo, Kai Li, Weiqiang Chen, Baolan Li, Yinlan Chen, Yin Cheng, Xiaoyan Si, Hanping Wang, Faguang Jin, Jianhua Shi, Jianying Zhou, Xiuwen Wang, Xiaotong Zhang, Li Zhang, Donglin Wang, Jianxing He, Mengzhao Wang, Kejun Nan, Yuankai Shi, Baohui Han, Qiming Wang

المصدر: Lung Cancer. 122:32-37

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Cancer Research, medicine.medical_specialty, Indoles, Lung Neoplasms, Constipation, medicine.medical_treatment, Antineoplastic Agents, Placebo, Targeted therapy, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Quality of life, Carcinoma, Non-Small-Cell Lung, Surveys and Questionnaires, Internal medicine, medicine, Humans, Lung cancer, Aged, Neoplasm Staging, Chemotherapy, business.industry, Cancer, Middle Aged, Placebo Effect, medicine.disease, Survival Analysis, humanities, Clinical trial, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Quality of Life, Quinolines, Female, medicine.symptom, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366fa91fcfbcbe6f96bd4465e39033d1Test
https://doi.org/10.1016/j.lungcan.2018.05.013Test

9

Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma

المؤلفون: Cuimeng Tian, Tongmei Zhang, Hui Jiang, Ji Ming Wang, Baolan Li, Guangrong Xia, Guimei Liu, Jiaqiang Huang, Yongxiang Xu

المصدر: Radiology and Oncology, Vol 55, Iss 1, Pp 66-76 (2020)
Radiology and Oncology

مصطلحات موضوعية: 0301 basic medicine, Male, medicine.medical_specialty, Lung Neoplasms, Postoperative radiotherapy, R895-920, Gastroenterology, 03 medical and health sciences, Medical physics. Medical radiology. Nuclear medicine, 0302 clinical medicine, Port (medical), Risk Factors, Internal medicine, Carcinoma, Non-Small-Cell Lung, piiia-n2, medicine, lung squamous cell carcinoma, Humans, Radiology, Nuclear Medicine and imaging, Lung cancer, Pathological, Neoplasm Staging, Retrospective Studies, Lung, business.industry, postoperative radiotherapy, Lung squamous cell carcinoma, respiratory system, Middle Aged, medicine.disease, lung adenocarcinoma, Prognosis, Survival Analysis, respiratory tract diseases, 030104 developmental biology, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Adenocarcinoma, Female, Radiotherapy, Adjuvant, Non small cell, business, Research Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9772db953ae8b819361b9ab3f8b8e1d4Test
https://pubmed.ncbi.nlm.nih.gov/33885242Test

10

Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)

المؤلفون: You Lu, Conghua Xie, Zhehai Wang, Xiaodong Mei, Baohui Han, Zhixiong Yang, Donglei Zhu, Jianying Zhou, M. Bi, Baolan Li, Lijun Wang, Wen Zhang, Nong Yang, Yunpeng Yang, Yong Song, Weimin Li, Zhiyong He, Ying Cheng, Shuyan Wang, Rui Ma, Juan Li, Zhuang Yu, Xiubao Ren, Yan Zhang, Qitao Yu, Jian Fang, Jifeng Feng, Rui Zhou, Yanqiu Zhao, Li Zhang, Hui Zhou, Shundong Cang, Gongyan Chen, Yingyi Wang

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 15(10)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b99d8e9dc5d07cd3f270abd0b55d3e84Test
https://pubmed.ncbi.nlm.nih.gov/33246599Test

تنقيح النتائج